Viewing Study NCT02857868


Ignite Creation Date: 2025-12-24 @ 5:28 PM
Ignite Modification Date: 2026-02-02 @ 9:23 AM
Study NCT ID: NCT02857868
Status: COMPLETED
Last Update Posted: 2020-12-08
First Post: 2016-04-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial to Evaluate the Pharmacokinetics of ABL001 in Healthy and Hepatic Impaired Subjects
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatic Impairment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatic Impairment View
None ABL001 View
None Child-Pugh View
None healthy subjects with normal hepatic function View